PI3K inhibitor MLN1117, Purity ≥98%

Cat. No.: X24-05-ZQ115

PI3K inhibitor MLN1117, Purity ≥98%

Synonym: 1268454-23-4; Serabelisib; INK1117; INK-1117; INK 1117; MLN 1117; MLN-1117; TAK-117; TAK 117; TAK117; PI3K inhibitor

  • CAS Number: 1268454-23-4
  • Compound CID: 70798655
Product Size
10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
MLN1117, soluble in DMSO and insoluble in ethanol and water, is a potent compound that inhibits PI3 kinase activity. It targets mTOR, p110α, p110β, p110δ, and p110γ.
Molecular Weight
363.13
Molecular Formula
C19H17N5O3
Targets
mTOR: 1670 nM; p110α: 15 nM; p110β: 4500 nM; p110δ: 13900 nM; p110γ: 1900 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 15 mg/mL (41.28 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
MLN1117 serves to explore PI3Kα inhibition and its role in cancer treatment.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.